Pereira E, Ferreira R, Hermelin B, Thomas G, Bernard C, Bertrand V, Nassiff H, Mendez del Castillo D, Bereziat G, Benlian P
Hospital Hermanos Ameijeiras, La Habana, Cuba.
Hum Genet. 1995 Sep;96(3):319-22. doi: 10.1007/BF00210415.
The molecular basis of familial hypercholesterolemia (FH) in three families of Spanish descent from La Habana was investigated by the candidate gene approach. The Arg3500Gln mutation of apolipoprotein B-100 was not found. Identification of low density lipoprotein receptor (LDLR) gene haplotypes segregating with FH guided the characterisation of three point mutations by automated sequencing. One, a Val408-->Met missense mutation, a founder mutation in Afrikaner FH patients, was recurrent, being associated with a distinct DNA haplotype. The other two, Glu256-->Lys and Val776-->Met missense mutations, were novel and modified highly conserved residues. These mutations were absent in normolipidemic subjects and were associated in heterozygous carriers with twice the cholesterol levels observed in non-carriers. Noticeably, cardiovascular complications were rarely observed in older heterozygotes, even in those with the Afrikaner FH-2 mutation. These findings confirm the molecular heterogeneity of LDLR gene mutations causing FH and the variability of their expression across different populations.
采用候选基因法对来自哈瓦那的三个西班牙裔家族的家族性高胆固醇血症(FH)的分子基础进行了研究。未发现载脂蛋白B - 100的Arg3500Gln突变。通过自动测序对与FH共分离的低密度脂蛋白受体(LDLR)基因单倍型进行鉴定,从而确定了三个点突变。其中一个是Val408→Met错义突变,这是非洲裔FH患者中的一个始祖突变,具有重复性,与一种独特的DNA单倍型相关。另外两个,Glu256→Lys和Val776→Met错义突变是新发现的,且改变了高度保守的残基。这些突变在血脂正常的受试者中不存在,在杂合子携带者中,其胆固醇水平是非携带者的两倍。值得注意的是,在老年杂合子中很少观察到心血管并发症,即使是那些携带非洲裔FH - 2突变的患者。这些发现证实了导致FH的LDLR基因突变的分子异质性以及它们在不同人群中表达的变异性。